Omega-3 and violence in schizophrenia

Schizophrenia Research

Volumn 96, Issue 1-3, 2007, Pages 269-

  Légaré, Nancy ^a   Brosseau, Élaine ^a   Joyal, Christian C ^a  

^a Institut Philippe Pinel de Montreal   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANXIOLYTIC AGENT; OMEGA 3 FATTY ACID;

AGGRESSION; AGITATION; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOGLYCEMIA; IMPULSIVENESS; LETTER; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME; VIOLENCE;

FATTY ACIDS, OMEGA-3; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VIOLENCE;

EID: 34848843447     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.05.023     Document Type: Letter

References (7)

1. Arvindakshan M., Ghate M., Ranjekar P.K., Evans D.R., and Mahadik S.P. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Research 62 (2003) 195-204
2. Horrobin D.F., Glen A.I.M., and Vaddadi K.S. The membrane hypothesis of schizophrenia. Schizophrenia Research 13 (1994) 195-208
3. Joy C.B., Mumby-Croft R., and Joy L.A. Polyunsaturated fatty acid supplementation for schizophrenia. The Cochrane Database of Systematic Reviews, Issue 3 (2006)
4. Gesch C.B., Hammond S.M., Hampson S.E., Eves A., and Crowder M.J. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. British Journal of Psychiatry 181 (2002) 22-28
5. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck Jr. P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 67 (2006) 1954-1967
6. Peet M., Brind J., Ramchand C.N., Shah S., and Vankar G.K. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophrenia Research 49 (2001) 243-251
7. Sagduyu K., Dokucu M.E., Eddy B.A., Craigen G., Baldassano C.F., and Yildiz A. Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study. Nutrition Journal 4 (2005) 1-6